fda may alter disclosure rules associated press washington the food and drug administration announced proposed rules to reduce potential conflicts of interest among outside experts who advise the government on approval of drugs and other regulated products the experts would have to disclose any financial ties to the industry under review experts on the advisory committees would have to fill out a form disclosing the potential conflicts and explaining why they should still be able to advise the agency if the fda agrees to a waiver the disclosure form would be posted on the fdas web site typically at least days before the committee meets under the current system outside advisers disclose potential conflicts to the fda the fda then announces when waivers are granted but doesnt routinely release the disclosure documents the proposed rules will be open for public comment for days before the fda makes a decision whether to revise or adopt them 
